Cargando…

Value in Hepatitis C Virus Treatment: A Patient-Centered Cost-Effectiveness Analysis

BACKGROUND: Innovations in hepatitis C virus (HCV) therapy included in traditional comparative evaluations focus on sustained virologic response (SVR) without addressing challenges patients report beyond virologic cure. This study aims to evaluate the cost-effectiveness of HCV drug therapy with a pa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mattingly, T. Joseph, Slejko, Julia F., Onukwugha, Eberechukwu, Perfetto, Eleanor M., Kottilil, Shyamasundaran, Mullins, C. Daniel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2019
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7081653/ https://www.ncbi.nlm.nih.gov/pubmed/31788751 http://dx.doi.org/10.1007/s40273-019-00864-8

Ejemplares similares

Burden of Co-Infection: A Cost Analysis of Human Immunodeficiency Virus in a Commercially Insured Hepatitis C Virus Population
por: Mattingly, T. Joseph, et al.
Publicado: (2019)

Reconstitution of T follicular helper-humoral immune axis with elimination of hepatitis C virus
por: Khanam, Arshi, et al.
Publicado: (2020)

The Economic Burden of Comorbid Obstructive Sleep Apnea Among Patients with Chronic Obstructive Pulmonary Disease
por: Hong, Yoon Duk, et al.
Publicado: (2020)

Estimating Drug Costs: How do Manufacturer Net Prices Compare with Other Common US Price References?
por: Mattingly, T. Joseph, et al.
Publicado: (2018)

Medical costs of Alpha-1 antitrypsin deficiency-associated COPD in the United States
por: Sieluk, Jan, et al.
Publicado: (2020)

Use of Ribavirin for Hepatitis C Treatment in the Modern Direct-acting Antiviral Era
por: Mathur, Poonam, et al.
Publicado: (2018)

Valuing diversity in value assessment: introducing the PhRMA Foundation Health Disparities Challenge Award
por: Onukwugha, Eberechukwu
Publicado: (2021)

Changes in Opioid Utilization Following Tumor Necrosis Factor Inhibitor Initiation in Patients with Rheumatoid Arthritis
por: Park, Siyeon, et al.
Publicado: (2019)

Economic burden of interstitial lung disease in a commercially insured population with Sjögren syndrome in the United States
por: Lee, Tsung-Ying, et al.
Publicado: (2022)

Sequential Therapies and the Cost-Effectiveness of Treating Metastatic Colon Cancer Patients
por: Woldemichael, Andinet, et al.
Publicado: (2016)

The Importance of Collaboration in Pursuit of Patient-Centered Value Assessment
por: Linthicum, Mark T., et al.
Publicado: (2020)

Cost-Effectiveness of Second-Line Chemotherapy/Biologics among Elderly Metastatic Colon Cancer Patients
por: Zheng, Zhiyuan, et al.
Publicado: (2014)

Eight Weeks of Ledipasvir/Sofosbuvir in Kidney Transplant Recipients With Hepatitis C Genotype 1 Infection
por: Husson, Jennifer S., et al.
Publicado: (2017)

Why the Gap in Evaluating the Social Constructs and the Value of Medicines?
por: McRae, Jacquelyn, et al.
Publicado: (2021)

Utilization of novel systemic therapies for multiple myeloma: A retrospective study of front‐line regimens using the SEER‐Medicare data
por: Goto, Daisuke, et al.
Publicado: (2019)

Clinical and demographic characteristics associated with the receipt of chemotherapy treatment among 7951 elderly metastatic colon cancer patients
por: Reese, Emily S, et al.
Publicado: (2013)

PCR80 Informing a Conceptual Framework for a Patient-Centered Value Assessment of Emerging Therapies for Mild/Moderate COVID-19
por: Ali, C, et al.
Publicado: (2022)

Big Data and Its Role in Health Economics and Outcomes Research: A Collection of Perspectives on Data Sources, Measurement, and Analysis
por: Onukwugha, Eberechukwu
Publicado: (2016)

Concordance between administrative claims and registry data for identifying metastasis to the bone: an exploratory analysis in prostate cancer
por: Onukwugha, Eberechukwu, et al.
Publicado: (2014)

Does the type of first-line regimens influence the receipt of second-line chemotherapy treatment? An analysis of 3211 metastatic colon cancer patients
por: Zheng, Zhiyuan, et al.
Publicado: (2014)

Patient Centeredness in Hepatitis C Direct-Acting Antiviral Treatment Delivery to People Who Inject Drugs: A Scoping Review
por: Abdelwadoud, Moaz, et al.
Publicado: (2020)

Changes in Cost-Effectiveness for Chronic Hepatitis C Virus Pharmacotherapy: The Case for Continuous Cost-Effectiveness Analyses
por: Mattingly, T. Joseph, et al.
Publicado: (2020)

Risk of skeletal related events among elderly prostate cancer patients by site of metastasis at diagnosis
por: Hussain, Arif, et al.
Publicado: (2016)

A Phase 2 open label study of ledipasvir/sofosbuvir for 12 weeks in subjects with hepatitis B virus infection
por: Price, Angie S., et al.
Publicado: (2022)

Immunomodulatory therapies for COVID-19
por: Mathur, Poonam, et al.
Publicado: (2022)

Toward Modified Impact Inventory Tables to Facilitate Patient-Centered Value Assessment
por: McQueen, R. Brett, et al.
Publicado: (2021)

Prevalence and risk of skeletal complications and use of radiation therapy in elderly women diagnosed with metastatic breast cancer
por: Hussain, Arif, et al.
Publicado: (2018)

A qualitative study to identify reasons for discharges against medical advice in the cardiovascular setting
por: Onukwugha, Eberechukwu, et al.
Publicado: (2012)

Cardiovascular event-free survival after adjuvant radiation therapy in breast cancer patients stratified by cardiovascular risk
por: Onwudiwe, Nneka C, et al.
Publicado: (2014)

Advances in hepatitis B therapeutics
por: Soriano, Vicente, et al.
Publicado: (2020)

Measurement of skeletal related events in SEER-Medicare: a comparison of claims-based methods
por: Aly, Abdalla, et al.
Publicado: (2015)

Durable Sustained Virologic Response After Oral Directly Acting Antiviral Therapy Despite Immunosuppressive Treatment
por: Hahn, Katherine J., et al.
Publicado: (2015)

A Sustainable Strategy to Prevent Misuse of Antibiotics for Acute Respiratory Infections
por: Rattinger, Gail B., et al.
Publicado: (2012)

Potential Use of Adjuvant Bacteriophage Therapy With Debridement, Antibiotics, and Implant Retention Surgery to Treat Chronic Prosthetic Joint Infections
por: Doub, James B, et al.
Publicado: (2021)

1060. Evaluation of ALT at Sustained Virologic Response (SVR) in Patients with Treated Hepatitis C Virus (HCV) Infection
por: Theppote, Amanda, et al.
Publicado: (2020)

Skeletal-related events and mortality among men diagnosed with advanced prostate cancer: The impact of alternative measures of radiation to the bone
por: Onukwugha, Eberechukwu, et al.
Publicado: (2017)

158 Hepatitis C Treatment Update: Current Status and Future Direcctions
por: Kottilil, Shyam
Publicado: (2014)

1067. Interferon-free Hepatitis C Treatment Increases Surrogates of Cardiovascular Disease Risk in Black Veterans
por: Mathur, Poonam, et al.
Publicado: (2020)

Epidemiological Determinants of Advanced Prostate Cancer in Elderly Men in the United States
por: Jayasekera, Jinani, et al.
Publicado: (2019)

Comparison of Price Index Methods and Drug Price Inflation Estimates for Hepatitis C Virus Medications
por: Mattingly, T. Joseph, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_fnq99hk7l130v7md6jkqa7su02